ACTIVE HALF-LIFE
2-3 days
CLASSIFICATION
Non-steroidal aromatase inhibitor
DOSAGE
0.5-1 mg over 1 to 3 days
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Hilma Biocare
LAB TEST
See Document
WAREHOUSE
EU Warehouse 3
SUBSTANCE
Letrozole
Letrozole is a powerful antitumor agent that functions as a non-steroidal selective aromatase inhibitor. Commonly prescribed for breast cancer treatment and post-menopausal therapy, this compound has also gained traction among athletes for its remarkable anti-estrogenic properties and ability to enhance muscle definition. Letrozole is renowned for being up to five times more effective than Anastrozole (Arimidex) in reducing the adverse effects linked to anabolic steroid use, making it an essential tool for those looking to lower estrogen levels and counteract elevated estradiol.
Athletes utilizing Letrozole can achieve a significant reduction in estrogen levels, effectively preventing aromatization.
Effects:While Letrozole is effective, potential side effects may include skin rashes, nausea, abdominal discomfort, fatigue, dizziness, headaches, elevated low-density cholesterol levels, and increased liver enzymes.
Side Effects:Before starting Letrozole, it is highly recommended to conduct preliminary blood tests. This step can lead to a marked decrease in estradiol levels and enhance your cycle's overall effectiveness. As a potent anti-estrogenic agent, Letrozole is frequently used during post-cycle therapy (PCT).
Protection:Although Letrozole shines during PCT, it can also be stacked with clomiphene or other steroids to create a well-rounded cycle.
Stacking: